Chargement en cours...

Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis

Insulin therapy is frequently required to achieve glycemic targets (A1c) in type 2 diabetes (T2D); however, clinicians and patients face barriers with the complexities of multiple daily injection regimens. Patch-like wearable insulin devices, such as V-Go, may simplify and optimize this complexity....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacy (Basel)
Auteurs principaux: Zeidan, Trisha, Nikkel, Carla, Dziengelewski, Beth, Wu, Stephanie, Chen, Aleda M. H.
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7712908/
https://ncbi.nlm.nih.gov/pubmed/33202616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmacy8040215
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!